Serum insulin-like growth factor binding protein 6 (IGFBP6) is increased in patients with type 1 diabetes and its complications

Shangsu Lu, Sharad B Purohit, Ashok Kumar Sharma, Wenbo Zhi, Mingfang He, Yiqian Wang, Chao Jun Li, Jin-Xiong She

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Insulin-like growth factor binding proteins (IGFBPs) are associated with insulin resistance and accelerated micro-and macro-vascular complications of diabetes. We investigated the relationship between serum levels of IGFBP6 in type-1 diabetes (T1D) patients and diabetic complications. In this study, IGFBP6 was measured in the sera from 697 T1D patients and 681 healthy controls using a Luminex assay. Mean serum levels of IGFBP6 were higher in T1D patients than controls matched for sex and age (119.7 vs 130.6 ng/ml, p < 10-4). Subject age, sex and duration of disease have a significant impact on serum IGFBP6 levels in both T1D patients and healthy controls. Patients with complications have significantly higher mean serum IGFBP6 than patients without any complication (p = 3.5×10-6). More importantly, conditional logistic regression analysis suggested that T1D patients are more likely to have very high levels of serum IGFBP6 (in the 4th quartile) (OR = 1.7) than healthy controls. Furthermore, T1D patients with various complications are more likely to have very high levels of serum IGFBP6 (in the 4th quartile) than patients without any complication (OR = 1.7-22.9). These results indicate the clinical importance of measuring IGFBP6 to the better management of T1D patients.

Original languageEnglish (US)
Pages (from-to)229-237
Number of pages9
JournalInternational Journal of Clinical and Experimental Medicine
Volume5
Issue number3
StatePublished - Jun 30 2012

Fingerprint

Insulin-Like Growth Factor Binding Protein 6
Diabetes Complications
Medical problems
Type 1 Diabetes Mellitus
Serum
Insulin-Like Growth Factor Binding Proteins
Regression analysis
Macros
Logistics
Assays
Blood Vessels
Insulin Resistance
Insulin

Keywords

  • Complications
  • Diabetes
  • Insulin resistance
  • Insulin-like growth factor binding proteins (IGFBPS)

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

@article{fd360dafc4ac489ea7af540098d6b77f,
title = "Serum insulin-like growth factor binding protein 6 (IGFBP6) is increased in patients with type 1 diabetes and its complications",
abstract = "Insulin-like growth factor binding proteins (IGFBPs) are associated with insulin resistance and accelerated micro-and macro-vascular complications of diabetes. We investigated the relationship between serum levels of IGFBP6 in type-1 diabetes (T1D) patients and diabetic complications. In this study, IGFBP6 was measured in the sera from 697 T1D patients and 681 healthy controls using a Luminex assay. Mean serum levels of IGFBP6 were higher in T1D patients than controls matched for sex and age (119.7 vs 130.6 ng/ml, p < 10-4). Subject age, sex and duration of disease have a significant impact on serum IGFBP6 levels in both T1D patients and healthy controls. Patients with complications have significantly higher mean serum IGFBP6 than patients without any complication (p = 3.5×10-6). More importantly, conditional logistic regression analysis suggested that T1D patients are more likely to have very high levels of serum IGFBP6 (in the 4th quartile) (OR = 1.7) than healthy controls. Furthermore, T1D patients with various complications are more likely to have very high levels of serum IGFBP6 (in the 4th quartile) than patients without any complication (OR = 1.7-22.9). These results indicate the clinical importance of measuring IGFBP6 to the better management of T1D patients.",
keywords = "Complications, Diabetes, Insulin resistance, Insulin-like growth factor binding proteins (IGFBPS)",
author = "Shangsu Lu and Purohit, {Sharad B} and Sharma, {Ashok Kumar} and Wenbo Zhi and Mingfang He and Yiqian Wang and Li, {Chao Jun} and Jin-Xiong She",
year = "2012",
month = "6",
day = "30",
language = "English (US)",
volume = "5",
pages = "229--237",
journal = "International Journal of Clinical and Experimental Medicine",
issn = "1940-5901",
publisher = "e-Century Publishing Corporation",
number = "3",

}

TY - JOUR

T1 - Serum insulin-like growth factor binding protein 6 (IGFBP6) is increased in patients with type 1 diabetes and its complications

AU - Lu, Shangsu

AU - Purohit, Sharad B

AU - Sharma, Ashok Kumar

AU - Zhi, Wenbo

AU - He, Mingfang

AU - Wang, Yiqian

AU - Li, Chao Jun

AU - She, Jin-Xiong

PY - 2012/6/30

Y1 - 2012/6/30

N2 - Insulin-like growth factor binding proteins (IGFBPs) are associated with insulin resistance and accelerated micro-and macro-vascular complications of diabetes. We investigated the relationship between serum levels of IGFBP6 in type-1 diabetes (T1D) patients and diabetic complications. In this study, IGFBP6 was measured in the sera from 697 T1D patients and 681 healthy controls using a Luminex assay. Mean serum levels of IGFBP6 were higher in T1D patients than controls matched for sex and age (119.7 vs 130.6 ng/ml, p < 10-4). Subject age, sex and duration of disease have a significant impact on serum IGFBP6 levels in both T1D patients and healthy controls. Patients with complications have significantly higher mean serum IGFBP6 than patients without any complication (p = 3.5×10-6). More importantly, conditional logistic regression analysis suggested that T1D patients are more likely to have very high levels of serum IGFBP6 (in the 4th quartile) (OR = 1.7) than healthy controls. Furthermore, T1D patients with various complications are more likely to have very high levels of serum IGFBP6 (in the 4th quartile) than patients without any complication (OR = 1.7-22.9). These results indicate the clinical importance of measuring IGFBP6 to the better management of T1D patients.

AB - Insulin-like growth factor binding proteins (IGFBPs) are associated with insulin resistance and accelerated micro-and macro-vascular complications of diabetes. We investigated the relationship between serum levels of IGFBP6 in type-1 diabetes (T1D) patients and diabetic complications. In this study, IGFBP6 was measured in the sera from 697 T1D patients and 681 healthy controls using a Luminex assay. Mean serum levels of IGFBP6 were higher in T1D patients than controls matched for sex and age (119.7 vs 130.6 ng/ml, p < 10-4). Subject age, sex and duration of disease have a significant impact on serum IGFBP6 levels in both T1D patients and healthy controls. Patients with complications have significantly higher mean serum IGFBP6 than patients without any complication (p = 3.5×10-6). More importantly, conditional logistic regression analysis suggested that T1D patients are more likely to have very high levels of serum IGFBP6 (in the 4th quartile) (OR = 1.7) than healthy controls. Furthermore, T1D patients with various complications are more likely to have very high levels of serum IGFBP6 (in the 4th quartile) than patients without any complication (OR = 1.7-22.9). These results indicate the clinical importance of measuring IGFBP6 to the better management of T1D patients.

KW - Complications

KW - Diabetes

KW - Insulin resistance

KW - Insulin-like growth factor binding proteins (IGFBPS)

UR - http://www.scopus.com/inward/record.url?scp=84864313055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864313055&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 229

EP - 237

JO - International Journal of Clinical and Experimental Medicine

JF - International Journal of Clinical and Experimental Medicine

SN - 1940-5901

IS - 3

ER -